TrialBreast cancer research : BCR2018

Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.

Marcus Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.